Janssen

ESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPC
Clinical Trials Arena
Tue, 09/17/24 - 11:13 am
Eli Lilly
ESMO
lutetium zadavotide guraxetan
Astellas
Janssen
metastatic castration-resistant prostate cancer
Evernorth Will Offer a Private-Label Stelara Biosimilar in 2025
Managed Healthcare Executive
Thu, 09/5/24 - 10:32 pm
Evernorth Health
Stelara
biosimilars
Janssen
JNJ
J&J drops Addex-partnered epilepsy drug after reviewing failed phase 2 trial data
Fierce Biotech
Thu, 07/18/24 - 11:20 am
JNJ
Addex Therapeutics
epilepsy
ADX71149
Janssen
J&J to seek appeal of $150M verdict in long-spanning HIV meds off-label marketing case
Fierce Pharma
Mon, 06/17/24 - 10:31 pm
JNJ
Janssen
off-label
HIV
legal
whistleblower lawsuits
Prezista
Intelence
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
Janssen’s antibody drug shows phase 2 potential in rheumatoid arthritis
Biopharma Reporter
Thu, 11/9/23 - 09:55 am
Janssen
JNJ
rheumatoid arthritis
nipocalimab
clinical trials
J&J books manufacturing space at Fujifilm Diosynth's upcoming mega-plant in North Carolina
Fierce Pharma
Wed, 11/8/23 - 09:57 pm
JNJ
Janssen
Fujifilm Diosynth Biotechnologies
CDMOs
North Carolina
GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy
Reuters
Tue, 10/31/23 - 10:18 am
GSK
JNJ
hepatitis B
JNJ-3989
Janssen
Janssen reports data from Phase III trial of lung cancer drug
Clinical Trials Arena
Tue, 10/24/23 - 10:21 am
JNJ
Janssen
Rybrevant
clinical trials
non-small cell lung cancer
Janssen tackles racial gap in Phase IIIb psoriasis trial with Tremfya
Clinical Trials Arena
Fri, 10/20/23 - 11:39 am
Janssen
psoriasis
Tremfya
clinical trials
Janssen’s Tremfya maintains three years of remission in Phase II Crohn’s disease trial
Clinical Trials Arena
Tue, 10/17/23 - 11:45 am
JNJ
Janssen
clinical trials
Crohn's Disease
Tremfya
Janssen and Atropos partner to expedite clinical development
Clinical Trials Arena
Thu, 09/28/23 - 10:10 am
JNJ
Janssen
Atropos Health
real world data
After Kenvue spinoff, J&J says it's 'uniting' Janssen and medtech segments under one brand
Fierce Pharma
Thu, 09/14/23 - 11:13 pm
JNJ
Janssen
Medtech
rebranding
J&J's patient assistance program suffers data breach, IBM says
Fierce Pharma
Thu, 09/7/23 - 09:43 am
JNJ
Janssen
IBM
patient assistance programs
cybersecurity
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
FDA
Sandoz
Novartis
Gilead Sciences
Pfizer
Neurocrine
Regeneron
Ipsen
Revance Therapeutics
Delcath Systems
Janssen
Galera Therapeutics
Biogen
Roche
Mesoblast
Taiho Oncology
Janssen granted additional European Commission approval for bispecific antibody
Biopharma Reporter
Tue, 08/22/23 - 09:54 am
Janssen
JNJ
bispecific antibodies
Europe
relapsed or refractory multiple myeloma
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Janssen’s newly-merged infectious disease and vaccine unit sees significant pipeline cuts
Fierce Biotech
Thu, 07/20/23 - 10:18 am
JNJ
Janssen
infectious disease
vaccines
hepatitis
HIV
Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
Medical Marketing and Media
Tue, 07/11/23 - 11:27 pm
JNJ
Janssen
Nanobiotix
NBTXR3
soft tissue sarcoma
Hensify
Janssen’s trial of plaque psoriasis therapy meets endpoints
Clinical Trials Arena
Wed, 07/5/23 - 10:18 am
Janssen
JNJ
clinical trials
JNJ-2113
plaque psoriasis

Pages